HRS-9821 Inhalation Suspension: Clinical Trials

1 trial of HRS-9821 Inhalation Suspension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow HRS-9821 Inhalation Suspension: new trials by email Literature Review of HRS-9821 Inhalation Suspension trials Research Report on HRS-9821 Inhalation Suspension

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
HRS-9821 Inhalation Suspension, HRS-9821 Placebo Inhalation Suspension - COPD
Phase 2RecruitingGuangdong Hengrui Pharmaceutical Co., Ltd902026-07-202026-08-18

Conditions studied

Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Guangdong Hengrui Pharmaceutical Co., Ltd (1)

Countries

China (1)